MAAT INDEX

CLAIM #48711 · Pfizer Inc (PFE) · 2026Q1 earnings call · May 5, 2026 · due Dec 31, 2028

As just a reminder, given the LOE headwinds over the next few years, we expect leverage to remain around the current levels or even slightly higher through the transition period.

David Denton · CFO

PENDING
graded after results covering Dec 31, 2028 are reported

How to check this claim

Look at: Net debt / adjusted EBITDA leverage ratio (as reported by company)

It came true if: Leverage ratio stays within approximately current level to slightly higher (roughly current level up to ~10-15% above current level) at each fiscal year-end through 2028

Where: Company financial statements / earnings call disclosures (leverage ratio or net debt and EBITDA figures, 10-K/10-Q filings)

Verify independently

SEC filings for PFE · Claim quote is verbatim from the 2026Q1 earnings call.